Canadian Cannabis News

German Retail Acquisition Pending for High Tide – New Cannabis Ventures

Published

7 months ago

August 17, 2025

admin

German Retail Acquisition Pending for High Tide – New Cannabis Ventures

The high wave will become a large player in the German medical center with the acquisition of shares in the Remexian Pharma GMBH

In the last 12 months, Remexian has income 65 million euros income
Remexian sold 7 tons of cannabis flower in the quarter of 2025, which is 43 tons of 16% imported to Germany in the quarter

Calgary, ABD, August 14, 2025 / PRNEWSWIRE / – High Tide Inc. (“High Termosity” or “Company”) (NASDAQ. HITI) (FSE: PHARMA GMBH (“Remexian”), 27.2 million euros (“transaction”) and will have an option to obtain the rest of interest in Remexia.

It was founded in 2018. Among the buyers of all Germany’s doctors, Remexian has one of the most popular in the world, which is currently licensed from 19 countries, including Canada, who represents about 33% of their total imports to Germany. Taking into account more than $ 1.9 billion from Canadian Canadian sales, a high channel has a Canadian shopping expertise and relationships to make this transaction significantly increase the Canadian Canadian department in Germany.

“Remexian is ideal for us, not only prices, but also with its operational approach, which prevents the highest price team. Said Raj Grover, the founder and CEO of the High Channel.

“With this high-quality acquisition, it’s about $ 100 million to significant EBITDA, we will talk about more affordable prices, which are imported to the highest quality brands,” Mr. Gurverer added.

“We are truly energy with a strong certigion that we have found with a high wave, the impressive scale of which enhances our influence in Germany,” said Remexyan co-founder Marcus Wenner. “Our two companies have deliberately have a strategic approach to becoming leaders in our relevant markets.

In April 2024, the demand for medical cannabis continued to accelerate in the country since the adoption of the German consumer Act of Germany. Over the past year, the number of medical cannabis has sharply increased by 250,000 to about 900,000 to 1 billion euros (BFAMM). 2025 (37.5 tons) and twelve months roll in total 134 tons, maintaining its place as the world’s largest medical importer. The growth of demand has also stimulated the position of Canada as a leading global exporter, the country’s German imports, about 36 tons in the first six months of 2025.

The Remexian, led by Francesco Baghan and Stefan Adome, is a leader in German Medical Cannabis, with an annual income, and 43 tons of 16 million euros and 15 million euros and a quarterly imported in Germany.

When the acquisition concluded, the company considered the potential of changes in Germany’s medical cannabis. The company believes that even if the restrictions are posted on telemedicine and postpone, which is subject to a long-term legislative review, the market will continue to grow after the adjustment period.

___________________________

_{Alcalculation agreements based on REMEX sales data and import numbers, which were publicly released by BFARM.}

_{Oursource. War of flowers’ prices. German boom, the reality of Great Britain}

_{³SOURCE: BFARM (Q2 2025 Update)}

_{Alcalculation agreements based on REMEX sales data and import numbers, which were publicly released by BFARM.}

Deal details

The transaction is subject to the wing length of time, among other things, it is necessary to exchange TSX enterprise (“TSXV”) and other customs conditions and are expected to be closed in the coming weeks. This implies a 53.4 million euros app that represents the 3,64065 times an annual Ebitda, which was created in six months of March 31, 2025, and is subject to certain adjustments based on working capital and closure. For 51% of the acquired equality, the preliminary estimated price of 27.2 million euros will be satisfied as follows:

42% of high-tidal tidal shares (“Ri-High Shares”) Price in US $ 2.1912, presenting the average average price for NASDAQ for NASDAQ.
29% cash.
29% of loans from sellers (“Credit”). The loan will ripen on December 31, 2029, annual annual interests (paid quarterly) will lead to a pre-payment company without penalty.

In addition to the above, the Remexian owners agreed to provide a high-channel option that acquires the remaining interests remaining in the Remexian through high tidal tide (“Call version”). The call option will be implemented at any time for a five (5) years of closing twenty four (24) monthly anniversary (“term” of the call version). The call option is carried out for the value of the enterprise, which is equal to the 12th Tebit Date of the Adjusted EBITDA, if the call version is performed in the first twelve (12) month of the call version. In addition, the high channel agreed to provide Remember owners to reset the remaining interests in high tidal lecture. Taking into account the option or set version, given the case, it will be satisfied with the Cash and High Combination Character at the discretion of the high wave. The call option has a minimum price of 15 million euros, and is subject to at least 40% of the payment of minimum cash, and the installed version is subject to at least 30% cash.

Any high levels related to the transaction are subject to four months and one day of stateration.

About a high wave

High Tide, Inc. is a leading community, retail Cannabis, developed to unleash the full cost of the world’s most powerful factory. The whole subsidiary of it, Canna Kabana, is the second largest brand of Cannabis in the world. High wave (HITI) is unique around cannabis consumer, fully diversified and fully integrated with all components of cannabis, including:

Bricks & Mortar Retail. Canna CABANA is Canada’s largest retail network in Canada, 203 Current places that pass through British Columbia, Alberta, Saskakateva, Manitoba, Ontario. In 2021, Kanina Cabana became the retail sale of the Cannabis Discount Club in the world.

Retail innovation. Fastendr ում is a unique and fully automated technology that uses retail kiosks to facilitate better purchase experience with observation, order and pickup.

Consumption accessories. The high wave operates the world’s leading e-commerce platforms, including grasscity.com, Smokecartel.com, DailyHighclub.com and Dankstop.com.

Brands. The list of HIGH Wave Industry and Consumer Brand includes Bud ™, Daily High Club Wea, Daily High Club ™, Vodka Glass Pass ™, Donezilla ™, Atomik ™ etc.

CBD. High channel continues to develop consumer CBD capabilities via Nuleafnaturals.com, fabcbd.de and brabscbd.co.uk.

Wholesale distribution. The high wave keeps the category of cannabis through wholesale solutions through Valiant.

Licensing. The high channel continues to push the culture of Cannabis through fresh partnership and license agreements under the name of the famous brandz.

The high tide is consistently moving forward before the fourth year in a row was named one of the best growing companies in Canada in 2024, as well as for the fastest growing companies in 1023. Tide, visit www.hightideinc.com. Do not miss high pages of high tidal tide in Sedan and Edgar for investment.

Original press release

Published by NCV NewsWire

NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number

Related Topics:Acquisition Cannabis German High Pending Retail Tide Ventures

Up Next

Cannabis Investors Should Consider REITs – New Cannabis Ventures

American Cannabis News

A Frightening Florida Medical Cannabis Market – New Cannabis Ventures

Published

2 weeks ago

March 5, 2026

admin

A Frightening Florida Medical Cannabis Market – New Cannabis Ventures

You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.

friends,

In May 2024 warned readers about Florida hemp field. There have been many follow-ups, the latest of which was in early January, and it pointed to the fact that Florida’s medical cannabis market is shrinking. Two months later, things look bleak there as the mature market becomes more competitive.

Each month we share BDSA data and Florida is one of the markets where they provide monthly sales estimates. Florida does a fantastic job of sharing weekly data on unit volumes, but it doesn’t provide revenue data.

The BDSA estimates Florida hemp sales totaled $126.1 million in February, down 0.4% from a year ago. January sales fell 4.1% from a year earlier, and 2025 sales are expected to rise just 2.9% after rising 20.9% in 2024.

Florida provides a wealth of data that allows for a good understanding of state trends. First, they provide the number of patients, which, according to 2/27 report was 933 thousand. Growth has slowed down.

During the last year, the growth was 3.4%, and in the last three months it increased by only 0.4%. Patient growth is projected to be 3.9% in 2025 and 3.3% in 2024, following an 11% increase in 2023. The medical cannabis industry is maturing in the state, and the current number of patients is almost 4% of the total population.

Florida shares the total number of stores (742 currently), which is up 4.7% year-over-year. Ahead of the election in 2024, which could legalize cannabis for adult use, there was a big increase, with the number of shops increasing by 14%. The growth of stores has led to more competition.

The state splits the volumes, and the two largest parts are “medical marijuana” in mg for THC products and “marijuana for smoking” in ounces. Sales of medical cannabis products rose 12.6% last week, while smoking cannabis grew 11.4%. This growth was much higher than the revenue growth projected by the BDSA, suggesting that pricing is under pressure.

Florida also breaks down unit sales by licensed operator and shares how many distribution locations each operates. This data shows how concentrated the state is, as 51.2% of the state’s vertically integrated dispensaries are owned by just four companies, including Trulieve, Verano (MÜV), Curaleaf, and Ayr Wellness (which bought Liberty Health). These four companies sold 56% of medical cannabis and 61% of smokable cannabis last week. Interestingly, Trulieve, which has nearly twice as many stores as runner-up Verano, saw its medical cannabis volumes decline from a year ago.

When voters failed to approve adult-use cannabis in 2024, falling short of the required 60% affirmative vote, these major Florida operators saw their stocks decimated. It’s been the hardest for Ayr Wellness, but they’ve all come down a lot.

It’s not yet known if Florida voters will vote again this year, but things could improve if adult legalization is implemented. Also, the federal ban on THC from hemp could increase demand later this year when it is implemented. With that said, Florida’s medical cannabis market appears to be struggling. Trulieve is very large in the state and has significant influence with it compared to other states. Analysts forecast Trulieve’s 2026 revenue to decline 1% after falling less than 1% in 2025. More importantly, they forecast adjusted EBITDA to decline 6% in 2026.

Sincerely,

Alan:

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we have published in the last 2 weeks.

Exclusives

Cannabis sales remained weak in February

Hemp stocks are stable

Financial statements

Cresco Labs saw revenue shrink again

Curaleaf’s Q4 revenue rose 2%

Follow Alan for real-time updates X.com:. Share and discover industry news with like-minded people on the largest group of cannabis investors and entrepreneurs LinkedIn:.

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El

In this article.

ayr health, AYRWF:, Cresco Labs, CRLBF:, Curaleaf:, curly, Florida, tcnnf:, WRONG:, to truly believe, summer, WITH:

aawh

Share Repurchases Are Not Always a Good Idea for Cannabis Companies – New Cannabis Ventures

Published

3 weeks ago

February 28, 2026

admin

friends,

Earnings season kicked off this week, and so far it’s been a mixed bag. Green Thumb Industries beat expectations, while Trulieve missed. Cronos Group also missed adjusted EBITDA despite falling revenue.

What’s most interesting to me about these quarterly reports are the updates we get in documents or press releases. A large category is share buybacks that are done.

GTI, which has a strong balance sheet, especially compared to other MSOs, has bought back more inventory. Cronos Group, which is cash- and debt-free, also bought some shares in November and December. These shares were acquired at close to tangible book value.

Trulieve did not report the share buyback, but the 10-K disclosed a 2025 bonus announced on 2/24 for CEO Rivers. The company has net cash, but its tangible book value is very negative and has deteriorated. The company does not buy back shares.

Ascend is set to report Q4 financials on 3/12 and it will be interesting to see if this very cheap stock company continues to buy back shares. The company has negative tangible book value, and the GTI 10-K disclosed that Ascend paid a $17 million penalty to GTI on 2/12, so I don’t expect it to be as aggressive with buybacks.

Stock buybacks seem like a good thing, especially when valuations are so low. However, investors should be wary of hemp companies buying back shares when they have balance sheet challenges.

Sincerely,

Alan:

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we have published in the last 2 weeks.

Exclusives

Canadian cannabis sales hit a new record high in December

Michigan hemp sales began in 2026

Financial statements

Green Thumb Industries’ revenue is rising as profitability improves

Trulieve Q4 revenue down 3%

Capital increase

Curaleaf took out $500M over 3 years at 11.5%

GTI increases borrowings by $50 million

Follow Alan for real-time updates X.com:. Share and discover industry news with like-minded people on the largest group of cannabis investors and entrepreneurs LinkedIn:.

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.

AKAN

Cannabis Stocks Held Steady – New Cannabis Ventures

Published

3 weeks ago

February 27, 2026

admin

Hemp stocks, as measured by the Global Hemp Stock Index, were quite volatile in 2024 and then again in 2025 as well. Although the index rose in December, it fell on the year. In January, the indicator decreased by 10.6%, reaching 5.89. February saw a drop in prices, but the market recovered with the index ending the month at 5.86, down 0.5%.

After collapsing 21.8% in late 2024 to 6.88 in Q4, the index fell heavily in Q1 and then marginally in Q2. The global hemp stock index, which now has 27 members, gained 53.0% in the third quarter but fell 14.2% in the fourth quarter, down 4.2% for the full year. In 2026, it decreased by 11.1%.

Since its peak in February 2021, the global hemp stock index is down 93.7% from a closing high of 92.48.

The 3 strongest names in February, each an MSO, were all up more than 13%;

Jazz Pharma rallied in 2026, but the other two declined.

February’s 3 weakest names are all down more than 13%;

All three have fallen significantly in 2026 so far.

We will summarize the performance of the index again in a month. In April, we historically combined the two articles, and we update here the other indexes that New Cannabis Ventures continues to maintain: the American Cannabis Operator Index, the Ancillary Cannabis Index, and the Canadian Cannabis LP Index.

American Hemp Operator Index

The ACOI sank in January, falling 12.5% to 11.53, and fell further in February, falling 5.8% to 10.87. In 2025, it increased by 57.7% to 13.18 and decreased by 17.5% in 2026. The large AdvisorShares Pure US Cannabis ETF ( MSOS ) fell 3.7% in February.

The strongest performing stock in February was TerrAscend (OTC: TSNDF ), up 7.7%. The weakest, Vireo Growth (OTC: VREOF ), fell 17.9%.

In March, the index will have seven members with the removals of Jushi Holdings (OTC: JUSHF ) and Vireo Growth.

Auxiliary cannabis index

Ancillary commodities lost 5.7% in February as the index fell to 9.84. The index decreased by 19.5% in 2025, reaching 11.09, and this year it decreased by 11.3%.

The strongest stock in February was Turning Point Brands (NASDAQ: TPB ), which rose 13.1%. The weakest iPower fell by 55.8%.

In March, the index will have seven members after the removal of GrowGeneration (NASDAQ: GRWG ), iPower (NASDAQ: IPW ) and Chicago Atlantic BDC (NASDAQ: LIEN ) during February’s low trading volume.

Canadian Hemp LP Index

Canadian LPs fell 0.9% in February as the index fell to 55.65. In 2025, the index increased by 17.8%, reaching 59.01, and in 2026, it decreased by 5.7%.

The strongest Canadian LP in February was Rubicon Organics (TSXV: ROMJ ), which rose 8.9%. Simply Insoluble Concentrates (TSXV: HASH ) was the weakest, down 27.8%.

In March, the index will have the same thirteen members.